Use of 5-fluorocytosine in systemic candidiasis in infancy.
D000935:Antifungal Agents / Q000627:therapeutic use*; D001769:Blood / Q000382:microbiology; D002176:Candida albicans; D002177:Candidiasis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D003596:Cytosine / Q000627:therapeutic use*; D004453:Echoencephalography; D005243:Feces / Q000382:microbiology; D005437:Flucytosine / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008286:Malabsorption Syndromes / Q000628:therapy; D008297:Male; D010288:Parenteral Nutrition / Q000009:adverse effects; D014556:Urine / Q000382:microbiology
D000935:Antifungal Agents; D005461:Fluorine; D003596:Cytosine; D005437:Flucytosine